Pharma Focus Asia

Piramal Pharma to Expand its Aurora Facility in Canada

Introduction:

Piramal Pharma Solution's business is investing US$188 million for the expansion of its Aurora facility in Canada.

Features:

The expansion will add a new state-of-the-art wing dedicated to manufacturing Active Pharmaceutical Ingredients (APIs).

The new facility will utilise ~10,500 sq. ft. of new manufacturing space and will enhance its offerings to customers with this new addition.

It will also support the manufacture of HPAPIs down to an Occupational Exposure Limit (OEL) of 1mcg/ m3.

The expansion will also include two new reactor suites, a dedicated filter dryer room, and a portable filter dryer.

Apart from these, it will also include filtration and drying capabilities that will increase service offerings at the Piramal Pharma Solutions Aurora facility.

The expansion is expected to be completed and be operational by April 30, 2021.

Specifications:

NamePiramal Pharma
TypeExpansion
BudgetUS$188 million
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?